Thu, Oct 23, 2014, 5:41 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • johnsmith33361@rocketmail.com johnsmith33361 Jul 10, 2013 5:06 PM Flag

    Inovio possesses a critical asset in the expertise of its senior management team, Board of Directors (* SEE BELOW )

    Inovio possesses a critical asset in the expertise of its senior management team, Board of Directors, and Scientific Advisory Board. The ability for Inovio to complete its mission of transforming medicine through the development of synthetic vaccines will depend upon the people guiding and executing Inovio’s business plan. Management is comprised of highly experienced individuals with entrepreneurial as well as big pharma experience across many facets of the biotech and pharmaceutical industries. Chief Executive Dr. Joseph Kim’s vision and enthusiasm has persuaded top business and medical professionals to join him in guiding Inovio. Among them are luminaries in medicine, business and science, such as Dr. David Weiner, recognized as the “father of DNA vaccines,” and other senior scientists, such as the developer of the rubella vaccine; and senior pharmaceutical and biotech executives and leaders with international expertise in bringing new vaccines through the regulatory process to commercialization.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INO
11.20+0.25(+2.28%)Oct 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.